Study on GS300 on NAFLD

NCT04887766 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonalcoholic Fatty Liver
Weight Loss

Interventions

DEVICE: GS300
DEVICE: Placebo

Sponsor

Gelesis, Inc.